City

Houston (1)

Memphis (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Baylor College of Medicine (1)

St. Jude Children's Research Hospital (1)

Collaborator

Center for Cell and Gene Therapy, Baylor College of Medicine (1)

Eli Lilly and Company (1)

The Methodist Hospital Research Institute (1)

Intervention

cyclophosphamide (1)

filgrastim (1)

gemcitabine (1)

her2-specific t cells (1)

peg-filgrastim (1)

prexasertib (1)

Study Documents

Intervention Type

biological (2)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

brain tumor, refractory

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting

Brain Tumor
+12 more

Prexasertib
+4 more

Memphis, Tennessee

St. Jude Children's Research Hospital

Oct 20, 2022

Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Houston (HER2-specific T cells)

Recruiting

Brain Tumor, Recurrent
Brain Tumor, Refractory

HER2-specific T cells

Houston, Texas
+1 more

May 3, 2022